Active substance |
iNOmax |
Holder |
Fluidda nv |
Status |
Running |
Indication |
patients who suffer from pulmonary hypertension associated with COPD and who participated in the PULSE-COPD-007 study |
Public documents |
|
Last update |
05/12/2017 |
iNOmax®
Last updated on 23/03/2023